Sotigalimab (Anti-TNFRSF5 / CD40)
Sotigalimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody targeting CD40. It can be used for the research of metastatic pancreatic adenocarcinoma.MW :144.54 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2635 |
| Sku # | A2635-1mg |
| Pricing | 1mg, $370.00 |